KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Incyte (INCY) EBITDA: 2010-2025

Historic EBITDA for Incyte (INCY) over the last 16 years, with Sep 2025 value amounting to $443.5 million.

  • Incyte's EBITDA rose 203.60% to $443.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2899.92%. This contributed to the annual value of $61.4 million for FY2024, which is 90.11% down from last year.
  • As of Q3 2025, Incyte's EBITDA stood at $443.5 million, which was down 16.37% from $530.3 million recorded in Q2 2025.
  • Incyte's EBITDA's 5-year high stood at $530.3 million during Q2 2025, with a 5-year trough of -$478.1 million in Q2 2024.
  • In the last 3 years, Incyte's EBITDA had a median value of $193.8 million in 2023 and averaged $169.2 million.
  • Its EBITDA has fluctuated over the past 5 years, first spiked by 4,320.02% in 2021, then crashed by 346.74% in 2024.
  • Incyte's EBITDA (Quarterly) stood at $110.7 million in 2021, then tumbled by 36.70% to $70.1 million in 2022, then soared by 167.17% to $187.3 million in 2023, then spiked by 61.00% to $301.5 million in 2024, then surged by 203.60% to $443.5 million in 2025.
  • Its last three reported values are $443.5 million in Q3 2025, $530.3 million for Q2 2025, and $205.2 million during Q1 2025.